Blogs2 sexual health

A report on Ruthy McIver's presentation "Men who have sex with men with Mycoplasma Genitalium-Positive Non-Gonococcal Urethritis are more likely to have macrolide resistant strains than men with only female partners"

This session contained a wide mix of 5-10 min presentations dealing with clinical research. Ruthy McIver’s presentation looked at the prevalence of Mycoplasma genitalium (MG) in men with non-gonococcal urethritis (NGU), both men who have sex with men (MSM) and men with female partners only (MSW), presenting to Sydney Sexual Health Centre (SSHC).

The final day’s plenary sessions were presentations based on the theme Building Bridges for the Next Generation. One of the presentations was by Reina Buijs from the Dutch Ministry of Foreign Affairs presenting “Mr Blue and other Dutch lessons in love” on the importance of comprehensive sexuality education for children and adolescents.

I noted a poster on treatment of anorectal chlamydia in MSM in Japan (Mizushima D et al). In Australia, the use of single dose of azithromycin  is questioned based on retrospective studies of its effectiveness. This prospective study followed 125 MSM with and without HIV with transcription mediated amplication confirmed anal chlamydia. They were all given AZM 1gm as a  single dose and then a test of cure at 3 weeks. If they failed the test of cure they were given Doxy 200mg daily for a week and tested again 3 weeks later. Of the 118  MSM treated (7 dropped out) 87% were cured by AZM. Of the the 15 who failed to AZM treatment 12 were treated  (3 dropped out) with Doxy and they were all cured.

There was no difference in effectiveness of AZM between HIV infected (97) and not HIV infected  (21) in responding to AZM